NCT06234930View on ClinicalTrials.gov

The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

July 11, 2024

Primary Completion Date

March 14, 2025

Study Completion Date

March 14, 2025

Conditions
Healthy AgingAlzheimer's Disease
Interventions
DEVICE

Audiovisual stimulation VR system

Delivery of synchronized auditory and visual stimuli at varying frequencies via a VR headset.

Trial Locations (2)

18503

The Sequoias Portola Valley, Portola Valley

34748

Lakeview Institute of Clinical Research LLC, Leesburg

Sponsors
All Listed Sponsors
lead

Clarity Health Technologies, Inc

INDUSTRY

NCT06234930 - The Feasibility, Safety and Tolerability of VR-based Audiovisual Stimulation | Biotech Hunter | Biotech Hunter